See more : Elior Group SA (ELORY) Income Statement Analysis – Financial Results
Complete financial analysis of PT Estee Gold Feet Tbk (EURO.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Estee Gold Feet Tbk, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- SK Square Co., Ltd. (402340.KS) Income Statement Analysis – Financial Results
- Takaoka Toko Co., Ltd. (6617.T) Income Statement Analysis – Financial Results
- G.E.T.T. Gold Inc. (RCCMF) Income Statement Analysis – Financial Results
- Cathedral Energy Services Ltd. (CET.TO) Income Statement Analysis – Financial Results
- IX Acquisition Corp. (IXAQW) Income Statement Analysis – Financial Results
PT Estee Gold Feet Tbk (EURO.JK)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.esteegoldaerosol.com
About PT Estee Gold Feet Tbk
PT Estee Gold Feet Tbk engages in the manufacture and sale of cosmetic products and household health supplies. The company offers cosmetic products, such as deodorant, eau de toilette, eau de parfum, eau de cologne, lotion, body perfume, perfume spray, and hair styling products; and household health supplies, including disinfectants, helmet and jacket antiseptics, air fresheners, car fresheners, and hand sanitizers. It also provides tolling services for aerosol and liquid preparations for cosmetic products, household products, and auto chemical products. The company was founded in 1978 and is headquartered in Jakarta Utara, Indonesia.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 23.78B | 30.32B | 24.88B | 18.79B |
Cost of Revenue | 16.41B | 21.82B | 16.24B | 11.75B |
Gross Profit | 7.37B | 8.50B | 8.64B | 7.05B |
Gross Profit Ratio | 30.98% | 28.03% | 34.73% | 37.49% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.55B | 2.93B | 4.48B | 2.90B |
Selling & Marketing | -300.83M | -182.39M | -75.43M | -215.38M |
SG&A | 4.25B | 2.75B | 4.40B | 2.69B |
Other Expenses | 13.80M | -12.31M | 0.00 | 0.00 |
Operating Expenses | 4.26B | 2.76B | 4.40B | 2.69B |
Cost & Expenses | 20.67B | 24.58B | 20.64B | 14.43B |
Interest Income | 238.58M | 62.43M | 223.86M | 104.44M |
Interest Expense | 50.08M | 5.17M | 4.13M | 2.19M |
Depreciation & Amortization | 1.72B | 999.03M | 874.51M | 793.66M |
EBITDA | 4.83B | 6.74B | 5.11B | 5.15B |
EBITDA Ratio | 20.31% | 22.23% | 20.56% | 27.42% |
Operating Income | 3.11B | 5.74B | 4.24B | 4.36B |
Operating Income Ratio | 13.07% | 18.93% | 17.04% | 23.19% |
Total Other Income/Expenses | 3.26B | 1.64B | 432.29M | -497.53M |
Income Before Tax | 6.37B | 7.38B | 4.67B | 3.86B |
Income Before Tax Ratio | 26.78% | 24.33% | 18.78% | 20.55% |
Income Tax Expense | 1.24B | 1.49B | 848.69M | 828.35M |
Net Income | 5.13B | 5.88B | 3.82B | 3.03B |
Net Income Ratio | 21.58% | 19.40% | 15.37% | 16.14% |
EPS | 2.02 | 2.35 | 7.65 | 6.07 |
EPS Diluted | 2.02 | 2.35 | 7.65 | 6.07 |
Weighted Avg Shares Out | 2.54B | 2.50B | 500.03M | 500.03M |
Weighted Avg Shares Out (Dil) | 2.54B | 2.50B | 500.03M | 500.03M |
Source: https://incomestatements.info
Category: Stock Reports